Gain (Loss) on Derivative Instruments, Net, Pretax
MetLife Gain (Loss) on Derivative Instruments, Net, Pretax increased by 111.5% to $74.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 82.9%, from $432.00M to $74.00M. Over 4 years (FY 2021 to FY 2025), Gain (Loss) on Derivative Instruments, Net, Pretax shows an upward trend with a -3.4% CAGR.
Analysis
How to read this metric
Large fluctuations indicate significant market exposure or hedging activity; consistent losses may suggest ineffective risk management.
Detailed definition
This represents the net change in fair value and realized gains or losses from derivative financial instruments used for...
Peer comparison
Standard for large financial institutions using derivatives to manage interest rate and market risk.
other_gain_loss_on_derivative_instruments_net_pretaxHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $421.00M | -$218.00M | -$196.00M | -$859.00M | -$1.20B | -$480.00M | $0.00 | -$90.00M | -$997.00M | -$1.20B | $0.00 | -$979.00M | -$508.00M | $767.00M | -$903.00M | $432.00M | -$796.00M | -$929.00M | -$646.00M | $74.00M |
| QoQ Change | — | -151.8% | +10.1% | -338.3% | -39.1% | +59.8% | +100.0% | — | <-999% | -20.6% | +100.0% | — | +48.1% | +251.0% | -217.7% | +147.8% | -284.3% | -16.7% | +30.5% | +111.5% |
| YoY Change | — | — | — | — | -383.8% | -120.2% | +100.0% | +89.5% | +16.6% | -150.4% | — | -987.8% | +49.0% | +163.8% | — | +144.1% | -56.7% | -221.1% | +28.5% | -82.9% |
Business Segments
| Segment | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 |
|---|---|---|---|---|---|---|---|---|
| Asia | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Corporate & Other | — | — | — | — | — | — | $0.00 | $0.00 |
| Corporate and Other | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| EMEA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Group Benefits | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Latin America | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| MetLife Holdings | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| U.S. | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — |
| Total | $0.00 | -$90.00M | -$997.00M | -$1.20B | $0.00 | -$979.00M | -$508.00M | $767.00M |
Asia, Corporate & Other, Corporate and Other, EMEA, Group Benefits, Latin America, MetLife Holdings, U.S. were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Gain (Loss) on Derivative Instruments, Net, Pretax at Other Companies
Frequently Asked Questions
- What is MetLife's gain (loss) on derivative instruments, net, pretax?
- MetLife (MET) reported gain (loss) on derivative instruments, net, pretax of $74.00M in Q1 2026.
- How has MetLife's gain (loss) on derivative instruments, net, pretax changed year-over-year?
- MetLife's gain (loss) on derivative instruments, net, pretax decreased by 82.9% year-over-year, from $432.00M to $74.00M.
- What is the long-term trend for MetLife's gain (loss) on derivative instruments, net, pretax?
- Over 4 years (2021 to 2025), MetLife's gain (loss) on derivative instruments, net, pretax has grown at a -3.4% compound annual growth rate (CAGR), from -$2.23B to -$1.94B.
- What does gain (loss) on derivative instruments, net, pretax mean?
- The net profit or loss from financial hedging contracts.